Viewing Study NCT00024661


Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2026-01-01 @ 5:20 AM
Study NCT ID: NCT00024661
Status: COMPLETED
Last Update Posted: 2011-04-13
First Post: 2001-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors
Sponsor: INSYS Therapeutics Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module